Retraction notice to “Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole” [Biomedicine & Pharmacotherapy 167 (2023) 115528]
- DOI
- 10.1016/j.biopha.2026.119194
- Published
- 2026-04
- Container
- Biomedicine & Pharmacotherapy
- Publisher
- Elsevier BV
- Open access
- unknown
Credibility signals
uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- supportingDOI registered: A matching record was returned by Crossref.
- supportingDOI resolves: A matching record was returned by Crossref.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- supportingMetadata completeness: All 6 scored descriptive metadata groups are present.
Cite this work
BibTeX
@article{allodium:10.1016/j.biopha.2026.119194,
title = {Retraction notice to “Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole” [Biomedicine \& Pharmacotherapy 167 (2023) 115528]},
author = {Dušica J. Popović and Kosta J. Popović and Dejan Miljković and Jovan K. Popović and Dušan Lalošević and Mihalj Poša and Zana Dolićanin and Ivan Čapo},
year = {2026},
journal = {Biomedicine \& Pharmacotherapy},
doi = {10.1016/j.biopha.2026.119194},
url = {https://doi.org/10.1016/j.biopha.2026.119194}
}RIS
TY - JOUR TI - Retraction notice to “Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole” [Biomedicine & Pharmacotherapy 167 (2023) 115528] AU - Dušica J. Popović AU - Kosta J. Popović AU - Dejan Miljković AU - Jovan K. Popović AU - Dušan Lalošević AU - Mihalj Poša AU - Zana Dolićanin AU - Ivan Čapo PY - 2026 JO - Biomedicine & Pharmacotherapy DO - 10.1016/j.biopha.2026.119194 UR - https://doi.org/10.1016/j.biopha.2026.119194 ER -
APA
Popović, D. J., Popović, K. J., Miljković, D., Popović, J. K., Lalošević, D., Poša, M., Dolićanin, Z., & Čapo, I. (2026). Retraction notice to “Diclofenac and metformin synergistic dose dependent inhibition of hamster fibrosarcoma, rescued with mebendazole” [Biomedicine & Pharmacotherapy 167 (2023) 115528]. Biomedicine & Pharmacotherapy. https://doi.org/10.1016/j.biopha.2026.119194
Source records
- crossref · retrieved 2026-09-26T07:57:35.670Z